BridgeMD
New treatment option for Laryseal Pro and Ambu Aura Gain as Conduits for Fiberoptic...
Official title A Comparative Study Between Laryseal Pro Extraglottic Device and Ambu Aura Gain Laryngeal Mask as a Conduit for Fiberoptic Tracheal Intubation in Pediatric Population
ClinicalTrials.gov ID: NCT06945029
What this study is testing
- What it's testing
- This study aims to compare between Laryseal Pro and Ambu Aura Gain extraglottic devices as conduits for fiberoptic endotracheal intubation regarding time of endotracheal intubation in pediatric population.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 8
You may be able to join if
- Age starting from 4 years to 8 years.
- Both genders.
- ASA physical status class I-ll.
- Apparently anatomically normal with normal percentile growth chart, not suspected to have difficult airway.
- Scheduled for day case surgeries more than one hour under general anesthesia.
You likely can't join if
- Parents refusal.
- Abnormality in head and neck or craniofacial anomalies as Piere Robbin syndrome, facial trauma, head and neck tumours, swellings and hemangiomas.
- Patients at risk of regurgitation and pulmonary aspiration such as patients with hiatus hernia, GERD or DM.
- Abnormal or contraindicated cervical spine flexion/extension/rotation.
- Allergy to any EAD components.
- Any active respiratory or cardiac disease and metabolic disorders.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Giza Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 8 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Giza Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.